Skip to content

Clinical trials

Observational Lung Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Observational Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20131
20163
20171
20181
20202
20231
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed4
Active, not recruiting3
Unknown status3
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Beijing Chao Yang Hospital1
Chang Chen1
Chinese Academy of Sciences1
Chinese PLA General Hospital1
ChromX Health1
Fifth Affiliated Hospital, Sun Yat-Sen University1
Maastricht University1
Peking University People's Hospital1
Peking University Third Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases17
Lung Neoplasms7
Carcinoma, Non-Small-Cell Lung5
Bronchial Neoplasms4
Carcinoma, Bronchogenic4
Neoplasms4
Pulmonary Disease, Chronic Obstructive4
Neoplasms by Site3
Respiratory Tract Diseases3
Respiratory Tract Neoplasms3

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.